LifeMD (LFMD) Common Equity (2016 - 2025)
LifeMD (LFMD) has disclosed Common Equity for 14 consecutive years, with $23.2 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Common Equity rose 406.54% year-over-year to $23.2 million, compared with a TTM value of $23.2 million through Dec 2025, up 406.54%, and an annual FY2025 reading of $23.2 million, up 406.54% over the prior year.
- Common Equity was $23.2 million for Q4 2025 at LifeMD, up from $3.4 million in the prior quarter.
- Across five years, Common Equity topped out at $23.2 million in Q4 2025 and bottomed at -$243.2 million in Q2 2025.
- Average Common Equity over 5 years is -$25.4 million, with a median of -$3.5 million recorded in 2024.
- The sharpest move saw Common Equity surged 1541.84% in 2022, then tumbled 12757.07% in 2025.
- Year by year, Common Equity stood at $21.7 million in 2021, then tumbled by 154.69% to -$11.9 million in 2022, then surged by 135.29% to $4.2 million in 2023, then plummeted by 280.33% to -$7.6 million in 2024, then skyrocketed by 406.54% to $23.2 million in 2025.
- Business Quant data shows Common Equity for LFMD at $23.2 million in Q4 2025, $3.4 million in Q3 2025, and -$243.2 million in Q2 2025.